- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04101422
Utilizing Augmented Reality as an Adjunct for Smoking Cessation
April 26, 2023 updated by: H. Lee Moffitt Cancer Center and Research Institute
Utilizing Augmented Reality as an Adjunct for Smoking Cessation; Development and Initial Validation
The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
197
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Currently smoking ≥ 3 cigarettes per day for the past year
- Breath carbon monoxide (CO) level ≥ 5 ppm
- Motivated to quit smoking
- Aim 1 & 2 Only: Valid home address in the Tampa Bay area
- Functioning telephone number
- Can speak, read, and write in English
- Aim 3: Must have a smartphone that participant is willing to use during the study
- Aim 3: Motivated to quit smoking within the next month
Exclusion Criteria:
- Regular use (e.g., no more than 1/3 of month) of other tobacco products (cigars)
- Household member already enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Development of Augmented Reality (AR) Application
Investigators will collaborate with an AR software specialist to develop AR stimuli that are embedded within a basic digital application.
|
|
Experimental: Pilot Testing of AR Application
AR stimuli (smoking, e.g, cigarette, ashtray, lighter; and non-smoking, e.g., pen, notebook, eraser) will be piloted on a small group of smokers to receive feedback and modify as needed.
Participants will answer questions from a 10 point Likert scale that will asses urge from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke) and reality/co-existence (how realistic the item looks, and it's integration into the environment), from 1 (Not at all) to 10 (Very Much).
Participants will then be asked additional open-ended questions about the quality of the images following the ratings of the images.
|
Participants will use an Augmented Reality (AR) application on smart phones.
The AR application will create simulated examples of AR stimuli (cigarettes, lighters, ashtrays) and non-smoking related stimuli (pens, notebook, eraser).
|
Experimental: Laboratory Validation of AR Stimuli Session 2: Extinction
Participants will be randomized into either the extinction or control group.
28 trials of AR cues will be presented for each group.
Both groups will receive the same neutral cue in Trial 1 (to establish baseline urge) and the same smoking cue in Trial 2 (for pre-test cue-reactivity).
The extinction group will receive smoking cues for trials 3-26, whereas the control group will receive neutral cues.
Both groups will receive matched smoking cues for trial (27) followed by matched neutral cues for the final trial (28), for post-test cuereactivity.
Each cue will be presented for 1 minute and will be shown 4 times in trials 3-26.
Following each cue, participants will complete the single-item measure of urge.
Following the final trial (28) for both groups, participants will be presented with one of their own cigarettes and asked to take at least one puff.
Latency to smoke will later be determined using time stamps on the video recording.
Session 2 is expected to last 1.25 hours.
|
Participants will use an Augmented Reality (AR) application on smart phones.
The AR application will create simulated examples of AR stimuli (cigarettes, lighters, ashtrays) as well as non-smoking images (pens, notebook, etc.) Their urge to smoke rating following each presentation will be compared from baseline urge to smoke.
The post-test urge to smoke will be compared between control group and extinction group.
|
Experimental: Laboratory Validation of AR Stimuli Session 1: Cue Reactivity
Participants will attend 1st lab based session that will test cue-reactivity.
Participant will be randomized to view either AR images, or in vivo items first.
Order of presentation of items will also be randomized within the type (AR or in vivo).Session 1 should last under 1 hour.
|
Participants will use an Augmented Reality (AR) application on smart phones.
The AR application will create simulated examples of smoking related AR stimuli (cigarettes, lighters, ashtrays) as well as non-smoking images (pens, notebook, etc.).
They will also be presented with real smoking (e.g., ashtray) and non-smoking (e.g., pencil) items.
Their urge to smoke rating following each presentation will be compared for AR images vs. vivo items, and smoking-related vs. non-smoking related.
|
Experimental: Testing AR Application
Participants will be instructed to use the AR app that presents smoking-related stimuli (cigarette, ashtray, lighter) in locations/situations where they typically smoke with the goal of at least 5 uses per day for 7 days.
Usage and rating data will be collected in real-time.
Participants will also be asked to rate their urge to smoke on the smartphone app at selected times.
Participants will complete a telephone interview to provide additional feedback on the app, answer questions related to smoking behavior, and receive an in-person interview on their perceptions of the app as a potential cessation tool.
Participants will use the smart phone application for 7 days.
|
Participants will use an Augmented Reality )AR) application on smart phones in locations and situations where they typically smoke.
the application will create simulated examples of AR stimuli (cigarettes, lighters, ashtrays).
Participants will have a goal of using application at least 5 times per day for 7 days.
Usage and rating data will be collected in real-time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urge to Smoke - Pilot Testing
Time Frame: Post-cue presentation on Day 1, immediately following cue presentation
|
Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
|
Post-cue presentation on Day 1, immediately following cue presentation
|
Urge to Smoke - AR Stimuli Session 1
Time Frame: Post-cue presentation on Day 1, immediately following cue presentation
|
Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
|
Post-cue presentation on Day 1, immediately following cue presentation
|
Urge to Smoke - AR Stimuli Session 2
Time Frame: Post-cue presentation on Day 1, immediately following cue presentation
|
Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
|
Post-cue presentation on Day 1, immediately following cue presentation
|
Urge to Smoke - Testing AR Application
Time Frame: Day 1 - First Day of App Use, immediately following cue presentation
|
Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
|
Day 1 - First Day of App Use, immediately following cue presentation
|
Urge to Smoke - Testing AR Application
Time Frame: Up to Day 7 - Last Day of App Use, immediately following cue presentation
|
Participants will rate their urge to smoke on a 10-point Likert scale from 1 (absolutely no urge to smoke) to 10 (strongest urge to smoke).
|
Up to Day 7 - Last Day of App Use, immediately following cue presentation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reality/Co-Existence - Pilot Testing
Time Frame: Day 1, immediately following cue presentation
|
Three items will be used to assess the quality of the AR experience.
Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?).
These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).
|
Day 1, immediately following cue presentation
|
Reality/Co-Existence - AR Stimuli Session 1
Time Frame: Day 1, immediately following cue presentation
|
Three items will be used to assess the quality of the AR experience.
Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?).
These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).
|
Day 1, immediately following cue presentation
|
Reality/Co-Existence - AR Stimuli Session 2
Time Frame: Day 1, immediately following cue presentation
|
Three items will be used to assess the quality of the AR experience.
Reality (How real did the object seem to you?) Environment Co-Existence (How well did the the object appear to be part of the scene?) and User Co-Existence (How much did you feel the object was right there in front of you?).
These 3 items will be assessed using a 10 point Likert Scale from from 1 (Not at all) to 10 (Very much).
|
Day 1, immediately following cue presentation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christine Vinci, Ph.D., Moffitt Cancer Center
- Principal Investigator: Thomas Brandon, Ph.D., Moffitt Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Brandon KO, Vinci C, Kleinjan M, Hernandez LM, Sawyer LE, Sutton SK, Brandon TH. Testing Augmented Reality for Eliciting Cue-Provoked Urges to Smoke: Toward Moving Cue-Exposure Into the Real World. Nicotine Tob Res. 2021 May 4;23(5):861-865. doi: 10.1093/ntr/ntaa259.
- Yang MJ, Brandon KO, Sutton SK, Kleinjan M, Sawyer LE, Brandon TH, Vinci C. Augmented reality as a novel approach for addiction treatment: development of a smoking cessation app. Ann Med. 2022 Dec;54(1):3096-3106. doi: 10.1080/07853890.2022.2140451.
- Yang MJ, Brandon KO, Sutton SK, Kleinjan M, Hernandez LM, Sawyer LE, Brandon TH, Vinci C. Augmented reality for extinction of cue-provoked urges to smoke: Proof of concept. Psychol Addict Behav. 2022 Dec;36(8):990-998. doi: 10.1037/adb0000868. Epub 2022 Jul 14.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2019
Primary Completion (Actual)
February 14, 2022
Study Completion (Actual)
February 14, 2022
Study Registration Dates
First Submitted
September 23, 2019
First Submitted That Met QC Criteria
September 23, 2019
First Posted (Actual)
September 24, 2019
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
April 26, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MCC-20007
- R34DA047598-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Augmented Reality 1
-
University of PittsburghNortheastern University; NSFRecruiting
-
Chinese University of Hong KongNot yet recruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedCentral Line ComplicationCanada
-
Stanford UniversityCompletedAcute Pain | Mobility Limitation | Spinal FusionUnited States
-
Brigham and Women's HospitalWithdrawnPain | Infection | MalignancyUnited States
-
Wayne State UniversityEnrolling by invitationSpecific Phobia, AnimalUnited States
-
University of VirginiaRecruitingPain, Acute | Vocal Cord Paralysis | Laryngeal Neoplasms | Vocal Fold PolypUnited States
-
Universidad Peruana Cayetano HerediaCompletedHospitalized ChildPeru
-
Thomas CarusoEnrolling by invitationHypoglycemia | Pediatric ALLUnited States